Click for best price
Biologics Biosimilars Market Size, Share 2023
| Market size in 2022 |
US$ 198790 million
|
Forecast Market size by 2029 |
US$ 277500 million
|
| Growth Rate |
CAGR of 4.9% |
Number of Pages |
112 Pages |
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original ?innovator? products, and can be manufactured when the original product's patent expires.
This report aims to provide a comprehensive presentation of the global market for Biologics and Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics and Biosimilars. This report contains market size and forecasts of Biologics and Biosimilars in global, including the following market information:
Global Biologics and Biosimilars Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Biologics and Biosimilars Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Biologics and Biosimilars companies in 2022 (%)
The global Biologics and Biosimilars market was valued at US$ 198790 million in 2022 and is projected to reach US$ 277500 million by 2029, at a CAGR of 4.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major global manufacturers of biologics and biosimilars are Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, Sansheng Pharmaceuticals, Changchun Gaoxin, CITICS Guojia, Baitai Biotech, Sijin Biotech, Cinda Biotech, Tonghua Dongbao, Ganli and Union Pharmaceuticals, etc. Roche, Amgen and AbbVie are the top three, with a combined market share of about 37%.
We surveyed the Biologics and Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologics and Biosimilars Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biologics and Biosimilars Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Others
Global Biologics and Biosimilars Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biologics and Biosimilars Market Segment Percentages, by Application, 2022 (%)
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Global Biologics and Biosimilars Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biologics and Biosimilars Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biologics and Biosimilars revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Biologics and Biosimilars revenues share in global market, 2022 (%)
Key companies Biologics and Biosimilars sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Biologics and Biosimilars sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biologics and Biosimilars, market overview.
Chapter 2: Global Biologics and Biosimilars market size in revenue and volume.
Chapter 3: Detailed analysis of Biologics and Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biologics and Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biologics and Biosimilars capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Biologics and Biosimilars Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 198790 million
|
| Forecast Market size by 2029 |
US$ 277500 million
|
| Growth Rate |
CAGR of 4.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
112 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biologics and Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologics and Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologics and Biosimilars Overall Market Size
2.1 Global Biologics and Biosimilars Market Size: 2022 VS 2029
2.2 Global Biologics and Biosimilars Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biologics and Biosimilars Sales: 2018-2029
3 Company Landscape
3.1 Top Biologics and Biosimilars Players in Global Market
3.2 Top Global Biologics and Biosimilars Companies Ranked by Revenue
3.3 Global Biologics and Biosimilars Revenue by Companies
3.4 Global Biologics and Biosimilars Sales by Companies
3.5 Global Biologics and Biosimilars Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biologics and Biosimilars Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biologics and Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biologics and Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Biologics and Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Biologics and Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biologics and Biosimilars Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Interferon
4.1.4 Erythropoietin
4.1.5 Insulin
4.1.6 Vaccines
4.1.7 Others
4.2 By Type - Global Biologics and Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Biologics and Biosimilars Revenue, 2018-2023
4.2.2 By Type - Global Biologics and Biosimilars Revenue, 2024-2029
4.2.3 By Type - Global Biologics and Biosimilars Revenue Market Share, 2018-2029
4.3 By Type - Global Biologics and Biosimilars Sales & Forecasts
4.3.1 By Type - Global Biologics and Biosimilars Sales, 2018-2023
4.3.2 By Type - Global Biologics and Biosimilars Sales, 2024-2029
4.3.3 By Type - Global Biologics and Biosimilars Sales Market Share, 2018-2029
4.4 By Type - Global Biologics and Biosimilars Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biologics and Biosimilars Market Size, 2022 & 2029
5.1.2 Tumor
5.1.3 Diabetes
5.1.4 Cardiovascular
5.1.5 Hemophilia
5.1.6 Others
5.2 By Application - Global Biologics and Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Biologics and Biosimilars Revenue, 2018-2023
5.2.2 By Application - Global Biologics and Biosimilars Revenue, 2024-2029
5.2.3 By Application - Global Biologics and Biosimilars Revenue Market Share, 2018-2029
5.3 By Application - Global Biologics and Biosimilars Sales & Forecasts
5.3.1 By Application - Global Biologics and Biosimilars Sales, 2018-2023
5.3.2 By Application - Global Biologics and Biosimilars Sales, 2024-2029
5.3.3 By Application - Global Biologics and Biosimilars Sales Market Share, 2018-2029
5.4 By Application - Global Biologics and Biosimilars Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Biologics and Biosimilars Market Size, 2022 & 2029
6.2 By Region - Global Biologics and Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Biologics and Biosimilars Revenue, 2018-2023
6.2.2 By Region - Global Biologics and Biosimilars Revenue, 2024-2029
6.2.3 By Region - Global Biologics and Biosimilars Revenue Market Share, 2018-2029
6.3 By Region - Global Biologics and Biosimilars Sales & Forecasts
6.3.1 By Region - Global Biologics and Biosimilars Sales, 2018-2023
6.3.2 By Region - Global Biologics and Biosimilars Sales, 2024-2029
6.3.3 By Region - Global Biologics and Biosimilars Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Biologics and Biosimilars Revenue, 2018-2029
6.4.2 By Country - North America Biologics and Biosimilars Sales, 2018-2029
6.4.3 US Biologics and Biosimilars Market Size, 2018-2029
6.4.4 Canada Biologics and Biosimilars Market Size, 2018-2029
6.4.5 Mexico Biologics and Biosimilars Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Biologics and Biosimilars Revenue, 2018-2029
6.5.2 By Country - Europe Biologics and Biosimilars Sales, 2018-2029
6.5.3 Germany Biologics and Biosimilars Market Size, 2018-2029
6.5.4 France Biologics and Biosimilars Market Size, 2018-2029
6.5.5 U.K. Biologics and Biosimilars Market Size, 2018-2029
6.5.6 Italy Biologics and Biosimilars Market Size, 2018-2029
6.5.7 Russia Biologics and Biosimilars Market Size, 2018-2029
6.5.8 Nordic Countries Biologics and Biosimilars Market Size, 2018-2029
6.5.9 Benelux Biologics and Biosimilars Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Biologics and Biosimilars Revenue, 2018-2029
6.6.2 By Region - Asia Biologics and Biosimilars Sales, 2018-2029
6.6.3 China Biologics and Biosimilars Market Size, 2018-2029
6.6.4 Japan Biologics and Biosimilars Market Size, 2018-2029
6.6.5 South Korea Biologics and Biosimilars Market Size, 2018-2029
6.6.6 Southeast Asia Biologics and Biosimilars Market Size, 2018-2029
6.6.7 India Biologics and Biosimilars Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Biologics and Biosimilars Revenue, 2018-2029
6.7.2 By Country - South America Biologics and Biosimilars Sales, 2018-2029
6.7.3 Brazil Biologics and Biosimilars Market Size, 2018-2029
6.7.4 Argentina Biologics and Biosimilars Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biologics and Biosimilars Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Biologics and Biosimilars Sales, 2018-2029
6.8.3 Turkey Biologics and Biosimilars Market Size, 2018-2029
6.8.4 Israel Biologics and Biosimilars Market Size, 2018-2029
6.8.5 Saudi Arabia Biologics and Biosimilars Market Size, 2018-2029
6.8.6 UAE Biologics and Biosimilars Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biologics and Biosimilars Major Product Offerings
7.1.4 Roche Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Biologics and Biosimilars Major Product Offerings
7.2.4 Amgen Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 AbbVie
7.3.1 AbbVie Company Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Biologics and Biosimilars Major Product Offerings
7.3.4 AbbVie Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.3.5 AbbVie Key News & Latest Developments
7.4 Sanofi-Aventis
7.4.1 Sanofi-Aventis Company Summary
7.4.2 Sanofi-Aventis Business Overview
7.4.3 Sanofi-Aventis Biologics and Biosimilars Major Product Offerings
7.4.4 Sanofi-Aventis Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi-Aventis Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Biologics and Biosimilars Major Product Offerings
7.5.4 Johnson & Johnson Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Biologics and Biosimilars Major Product Offerings
7.6.4 Pfizer Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Novo Nordisk
7.7.1 Novo Nordisk Company Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Biologics and Biosimilars Major Product Offerings
7.7.4 Novo Nordisk Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.7.5 Novo Nordisk Key News & Latest Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Company Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Biologics and Biosimilars Major Product Offerings
7.8.4 Eli Lilly Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.8.5 Eli Lilly Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Biologics and Biosimilars Major Product Offerings
7.9.4 Novartis Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck Biologics and Biosimilars Major Product Offerings
7.10.4 Merck Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.10.5 Merck Key News & Latest Developments
7.11 3sbio
7.11.1 3sbio Company Summary
7.11.2 3sbio Biologics and Biosimilars Business Overview
7.11.3 3sbio Biologics and Biosimilars Major Product Offerings
7.11.4 3sbio Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.11.5 3sbio Key News & Latest Developments
7.12 Changchun High Tech
7.12.1 Changchun High Tech Company Summary
7.12.2 Changchun High Tech Biologics and Biosimilars Business Overview
7.12.3 Changchun High Tech Biologics and Biosimilars Major Product Offerings
7.12.4 Changchun High Tech Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.12.5 Changchun High Tech Key News & Latest Developments
7.13 CP Guojian
7.13.1 CP Guojian Company Summary
7.13.2 CP Guojian Biologics and Biosimilars Business Overview
7.13.3 CP Guojian Biologics and Biosimilars Major Product Offerings
7.13.4 CP Guojian Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.13.5 CP Guojian Key News & Latest Developments
7.14 Biotech
7.14.1 Biotech Company Summary
7.14.2 Biotech Business Overview
7.14.3 Biotech Biologics and Biosimilars Major Product Offerings
7.14.4 Biotech Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.14.5 Biotech Key News & Latest Developments
7.15 Gelgen
7.15.1 Gelgen Company Summary
7.15.2 Gelgen Business Overview
7.15.3 Gelgen Biologics and Biosimilars Major Product Offerings
7.15.4 Gelgen Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.15.5 Gelgen Key News & Latest Developments
7.16 Innovent
7.16.1 Innovent Company Summary
7.16.2 Innovent Business Overview
7.16.3 Innovent Biologics and Biosimilars Major Product Offerings
7.16.4 Innovent Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.16.5 Innovent Key News & Latest Developments
7.17 Dong Bao
7.17.1 Dong Bao Company Summary
7.17.2 Dong Bao Business Overview
7.17.3 Dong Bao Biologics and Biosimilars Major Product Offerings
7.17.4 Dong Bao Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.17.5 Dong Bao Key News & Latest Developments
7.18 Ganlee
7.18.1 Ganlee Company Summary
7.18.2 Ganlee Business Overview
7.18.3 Ganlee Biologics and Biosimilars Major Product Offerings
7.18.4 Ganlee Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.18.5 Ganlee Key News & Latest Developments
7.19 United Laboratories
7.19.1 United Laboratories Company Summary
7.19.2 United Laboratories Business Overview
7.19.3 United Laboratories Biologics and Biosimilars Major Product Offerings
7.19.4 United Laboratories Biologics and Biosimilars Sales and Revenue in Global (2018-2023)
7.19.5 United Laboratories Key News & Latest Developments
8 Global Biologics and Biosimilars Production Capacity, Analysis
8.1 Global Biologics and Biosimilars Production Capacity, 2018-2029
8.2 Biologics and Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Biologics and Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biologics and Biosimilars Supply Chain Analysis
10.1 Biologics and Biosimilars Industry Value Chain
10.2 Biologics and Biosimilars Upstream Market
10.3 Biologics and Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biologics and Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Biologics and Biosimilars in Global Market
Table 2. Top Biologics and Biosimilars Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Biologics and Biosimilars Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Biologics and Biosimilars Revenue Share by Companies, 2018-2023
Table 5. Global Biologics and Biosimilars Sales by Companies, (K Units), 2018-2023
Table 6. Global Biologics and Biosimilars Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Biologics and Biosimilars Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Biologics and Biosimilars Product Type
Table 9. List of Global Tier 1 Biologics and Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologics and Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biologics and Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Biologics and Biosimilars Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Biologics and Biosimilars Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Biologics and Biosimilars Sales (K Units), 2018-2023
Table 15. By Type - Global Biologics and Biosimilars Sales (K Units), 2024-2029
Table 16. By Application ? Global Biologics and Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Biologics and Biosimilars Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Biologics and Biosimilars Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Biologics and Biosimilars Sales (K Units), 2018-2023
Table 20. By Application - Global Biologics and Biosimilars Sales (K Units), 2024-2029
Table 21. By Region ? Global Biologics and Biosimilars Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Biologics and Biosimilars Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Biologics and Biosimilars Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Biologics and Biosimilars Sales (K Units), 2018-2023
Table 25. By Region - Global Biologics and Biosimilars Sales (K Units), 2024-2029
Table 26. By Country - North America Biologics and Biosimilars Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Biologics and Biosimilars Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Biologics and Biosimilars Sales, (K Units), 2018-2023
Table 29. By Country - North America Biologics and Biosimilars Sales, (K Units), 2024-2029
Table 30. By Country - Europe Biologics and Biosimilars Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Biologics and Biosimilars Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Biologics and Biosimilars Sales, (K Units), 2018-2023
Table 33. By Country - Europe Biologics and Biosimilars Sales, (K Units), 2024-2029
Table 34. By Region - Asia Biologics and Biosimilars Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Biologics and Biosimilars Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Biologics and Biosimilars Sales, (K Units), 2018-2023
Table 37. By Region - Asia Biologics and Biosimilars Sales, (K Units), 2024-2029
Table 38. By Country - South America Biologics and Biosimilars Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Biologics and Biosimilars Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Biologics and Biosimilars Sales, (K Units), 2018-2023
Table 41. By Country - South America Biologics and Biosimilars Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Biologics and Biosimilars Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Biologics and Biosimilars Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Biologics and Biosimilars Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Biologics and Biosimilars Sales, (K Units), 2024-2029
Table 46. Roche Company Summary
Table 47. Roche Biologics and Biosimilars Product Offerings
Table 48. Roche Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Biologics and Biosimilars Product Offerings
Table 52. Amgen Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. AbbVie Company Summary
Table 55. AbbVie Biologics and Biosimilars Product Offerings
Table 56. AbbVie Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. AbbVie Key News & Latest Developments
Table 58. Sanofi-Aventis Company Summary
Table 59. Sanofi-Aventis Biologics and Biosimilars Product Offerings
Table 60. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Sanofi-Aventis Key News & Latest Developments
Table 62. Johnson & Johnson Company Summary
Table 63. Johnson & Johnson Biologics and Biosimilars Product Offerings
Table 64. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Johnson & Johnson Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Biologics and Biosimilars Product Offerings
Table 68. Pfizer Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Novo Nordisk Company Summary
Table 71. Novo Nordisk Biologics and Biosimilars Product Offerings
Table 72. Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Novo Nordisk Key News & Latest Developments
Table 74. Eli Lilly Company Summary
Table 75. Eli Lilly Biologics and Biosimilars Product Offerings
Table 76. Eli Lilly Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Eli Lilly Key News & Latest Developments
Table 78. Novartis Company Summary
Table 79. Novartis Biologics and Biosimilars Product Offerings
Table 80. Novartis Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Novartis Key News & Latest Developments
Table 82. Merck Company Summary
Table 83. Merck Biologics and Biosimilars Product Offerings
Table 84. Merck Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Merck Key News & Latest Developments
Table 86. 3sbio Company Summary
Table 87. 3sbio Biologics and Biosimilars Product Offerings
Table 88. 3sbio Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. 3sbio Key News & Latest Developments
Table 90. Changchun High Tech Company Summary
Table 91. Changchun High Tech Biologics and Biosimilars Product Offerings
Table 92. Changchun High Tech Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Changchun High Tech Key News & Latest Developments
Table 94. CP Guojian Company Summary
Table 95. CP Guojian Biologics and Biosimilars Product Offerings
Table 96. CP Guojian Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. CP Guojian Key News & Latest Developments
Table 98. Biotech Company Summary
Table 99. Biotech Biologics and Biosimilars Product Offerings
Table 100. Biotech Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Biotech Key News & Latest Developments
Table 102. Gelgen Company Summary
Table 103. Gelgen Biologics and Biosimilars Product Offerings
Table 104. Gelgen Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Gelgen Key News & Latest Developments
Table 106. Innovent Company Summary
Table 107. Innovent Biologics and Biosimilars Product Offerings
Table 108. Innovent Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Innovent Key News & Latest Developments
Table 110. Dong Bao Company Summary
Table 111. Dong Bao Biologics and Biosimilars Product Offerings
Table 112. Dong Bao Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 113. Dong Bao Key News & Latest Developments
Table 114. Ganlee Company Summary
Table 115. Ganlee Biologics and Biosimilars Product Offerings
Table 116. Ganlee Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 117. Ganlee Key News & Latest Developments
Table 118. United Laboratories Company Summary
Table 119. United Laboratories Biologics and Biosimilars Product Offerings
Table 120. United Laboratories Biologics and Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 121. United Laboratories Key News & Latest Developments
Table 122. Biologics and Biosimilars Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 123. Global Biologics and Biosimilars Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global Biologics and Biosimilars Production by Region, 2018-2023 (K Units)
Table 125. Global Biologics and Biosimilars Production by Region, 2024-2029 (K Units)
Table 126. Biologics and Biosimilars Market Opportunities & Trends in Global Market
Table 127. Biologics and Biosimilars Market Drivers in Global Market
Table 128. Biologics and Biosimilars Market Restraints in Global Market
Table 129. Biologics and Biosimilars Raw Materials
Table 130. Biologics and Biosimilars Raw Materials Suppliers in Global Market
Table 131. Typical Biologics and Biosimilars Downstream
Table 132. Biologics and Biosimilars Downstream Clients in Global Market
Table 133. Biologics and Biosimilars Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biologics and Biosimilars Segment by Type in 2022
Figure 2. Biologics and Biosimilars Segment by Application in 2022
Figure 3. Global Biologics and Biosimilars Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biologics and Biosimilars Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biologics and Biosimilars Revenue, 2018-2029 (US$, Mn)
Figure 7. Biologics and Biosimilars Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biologics and Biosimilars Revenue in 2022
Figure 9. By Type - Global Biologics and Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Biologics and Biosimilars Revenue Market Share, 2018-2029
Figure 11. By Type - Global Biologics and Biosimilars Sales Market Share, 2018-2029
Figure 12. By Type - Global Biologics and Biosimilars Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Biologics and Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Biologics and Biosimilars Revenue Market Share, 2018-2029
Figure 15. By Application - Global Biologics and Biosimilars Sales Market Share, 2018-2029
Figure 16. By Application - Global Biologics and Biosimilars Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Biologics and Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Biologics and Biosimilars Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Biologics and Biosimilars Revenue Market Share, 2018-2029
Figure 20. By Region - Global Biologics and Biosimilars Sales Market Share, 2018-2029
Figure 21. By Country - North America Biologics and Biosimilars Revenue Market Share, 2018-2029
Figure 22. By Country - North America Biologics and Biosimilars Sales Market Share, 2018-2029
Figure 23. US Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Biologics and Biosimilars Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Biologics and Biosimilars Sales Market Share, 2018-2029
Figure 28. Germany Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 29. France Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Biologics and Biosimilars Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Biologics and Biosimilars Sales Market Share, 2018-2029
Figure 37. China Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 41. India Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Biologics and Biosimilars Revenue Market Share, 2018-2029
Figure 43. By Country - South America Biologics and Biosimilars Sales Market Share, 2018-2029
Figure 44. Brazil Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Biologics and Biosimilars Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Biologics and Biosimilars Sales Market Share, 2018-2029
Figure 48. Turkey Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Biologics and Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 52. Global Biologics and Biosimilars Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Biologics and Biosimilars by Region, 2022 VS 2029
Figure 54. Biologics and Biosimilars Industry Value Chain
Figure 55. Marketing Channels
